• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性炎性肌病患者的冠心病和心血管危险因素:一项系统评价和荟萃分析

Coronary Heart Disease and Cardiovascular Risk Factors in Patients With Idiopathic Inflammatory Myopathies: A Systemic Review and Meta-Analysis.

作者信息

Qin Li, Li Fang, Luo Qiang, Chen Lifang, Yang Xiaoqian, Wang Han

机构信息

Department of Cardiology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.

Department of Rheumatology, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.

出版信息

Front Med (Lausanne). 2022 Jan 14;8:808915. doi: 10.3389/fmed.2021.808915. eCollection 2021.

DOI:10.3389/fmed.2021.808915
PMID:35096896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8795615/
Abstract

OBJECTIVES

It is well-established that the association between atherosclerotic cardiovascular diseases (ASCVD) and connective tissue diseases (CTDs), but the relationship between coronary heart disease (CHD) and idiopathic inflammatory myopathies (IIMs) remains controversial yet. The aim of this meta-analysis is to systematically evaluate the risk of CHD in IIMs patients. In addition, we explore differences in traditional cardiovascular risk factors between IIMs patients and controls.

METHODS

We searched Pubmed, EMBASE and Cochrane databases to identify relevant observational studies published in English up to August 2021. Pooled relative risk (RR) and 95% confidence interval (CI) was calculated using the generic inverse variance method for the risk of CHD. A meta-proportion analysis was conducted to assess differences in cardiovascular risk factors between two groups.

RESULTS

A total of 15 studies met inclusion criteria: seven studies focused on CHD and nine studies focused on traditional cardiovascular risk factors. The results demonstrated that IIMs patients had a higher risk of CHD (RR = 2.19, 95% CI: 1.40-3.42). Hypertension (OR = 1.44, 95% CI: 1.28-1.61), diabetes mellitus (OR = 1.67, 95% CI: 1.55-1.81) and dyslipidemia (OR = 1.48, 95% CI: 1.19-1.84) were more prevalent in IIMs patients compared with controls. However, there was a significant heterogeneity among studies assessing the risk of CHD and hypertension. Subgroup analysis demonstrated that definition of CHD, country and sample size may be potential sources of heterogeneity.

CONCLUSIONS

IIMs patients were at increased risk of CHD, and traditional cardiovascular risk factors appeared more prevalent in IIMs patients. This systemic review offers the proof that early appropriate interventions could reduce cardiovascular-associated morbidity and mortality in IIMs patients.

摘要

目的

动脉粥样硬化性心血管疾病(ASCVD)与结缔组织病(CTD)之间的关联已得到充分证实,但冠心病(CHD)与特发性炎性肌病(IIM)之间的关系仍存在争议。本荟萃分析的目的是系统评估IIM患者患CHD的风险。此外,我们探讨IIM患者与对照组在传统心血管危险因素方面的差异。

方法

我们检索了PubMed、EMBASE和Cochrane数据库,以识别截至2021年8月发表的相关英文观察性研究。使用通用逆方差法计算CHD风险的合并相对风险(RR)和95%置信区间(CI)。进行荟萃比例分析以评估两组之间心血管危险因素的差异。

结果

共有15项研究符合纳入标准:7项研究关注CHD,9项研究关注传统心血管危险因素。结果表明,IIM患者患CHD的风险更高(RR = 2.19,95% CI:1.40 - 3.42)。与对照组相比,高血压(OR = 1.44,95% CI:1.28 - 1.61)、糖尿病(OR = 1.67,95% CI:1.55 - 1.81)和血脂异常(OR = 1.48,95% CI:1.19 - 1.84)在IIM患者中更为普遍。然而,在评估CHD和高血压风险的研究之间存在显著异质性。亚组分析表明,CHD的定义、国家和样本量可能是异质性的潜在来源。

结论

IIM患者患CHD的风险增加,传统心血管危险因素在IIM患者中似乎更为普遍。这项系统评价提供了证据,表明早期适当干预可以降低IIM患者心血管相关的发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/6eb3bf5dd631/fmed-08-808915-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/648d826cdad9/fmed-08-808915-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/cafbb440638a/fmed-08-808915-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/6eb3bf5dd631/fmed-08-808915-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/648d826cdad9/fmed-08-808915-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/cafbb440638a/fmed-08-808915-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca9b/8795615/6eb3bf5dd631/fmed-08-808915-g0003.jpg

相似文献

1
Coronary Heart Disease and Cardiovascular Risk Factors in Patients With Idiopathic Inflammatory Myopathies: A Systemic Review and Meta-Analysis.特发性炎性肌病患者的冠心病和心血管危险因素:一项系统评价和荟萃分析
Front Med (Lausanne). 2022 Jan 14;8:808915. doi: 10.3389/fmed.2021.808915. eCollection 2021.
2
The risk of ischemic stroke in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.特发性炎性肌病患者的缺血性卒中风险:系统评价和荟萃分析。
Clin Rheumatol. 2021 Oct;40(10):4101-4108. doi: 10.1007/s10067-021-05751-2. Epub 2021 May 1.
3
Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.利妥昔单抗治疗特发性炎性肌病患者的疗效和安全性:系统评价和荟萃分析。
Front Immunol. 2022 Dec 12;13:1051609. doi: 10.3389/fimmu.2022.1051609. eCollection 2022.
4
Assessment of diagnostic utility, clinical phenotypic associations, and prognostic significance of anti-NXP2 autoantibody in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.抗NXP2自身抗体在特发性炎性肌病患者中的诊断效用、临床表型关联及预后意义评估:一项系统综述和荟萃分析
Clin Rheumatol. 2021 Mar;40(3):819-832. doi: 10.1007/s10067-020-05291-1. Epub 2020 Jul 17.
5
Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review.特发性炎性肌病患者心血管危险因素的评估:一项系统评价
Clin Rheumatol. 2023 Nov;42(11):2943-2950. doi: 10.1007/s10067-023-06633-5. Epub 2023 May 16.
6
Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies.残余胆固醇在冠心病患者中的预后价值:队列研究的系统评价和荟萃分析
Front Cardiovasc Med. 2023 Jan 19;9:951523. doi: 10.3389/fcvm.2022.951523. eCollection 2022.
7
The poor performance of cardiovascular risk scores in identifying patients with idiopathic inflammatory myopathies at high cardiovascular risk.心血管风险评分在识别具有高心血管风险的特发性炎性肌病患者方面表现不佳。
Open Med (Wars). 2023 May 17;18(1):20230703. doi: 10.1515/med-2023-0703. eCollection 2023.
8
Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies.特发性炎性肌病患者高血压预测模型的建立。
J Clin Hypertens (Greenwich). 2021 Aug;23(8):1556-1566. doi: 10.1111/jch.14267. Epub 2021 May 11.
9
10
Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis.脂联素水平与冠心病和死亡率的关系:系统评价和荟萃分析。
Int J Epidemiol. 2013 Aug;42(4):1029-39. doi: 10.1093/ije/dyt087. Epub 2013 Jun 4.

引用本文的文献

1
Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non-Concurrent Cohort Study.包涵体肌炎患者心肌梗死风险增加:一项非同期队列研究
Eur J Neurol. 2025 May;32(5):e70177. doi: 10.1111/ene.70177.
2
Cardiovascular manifestations in idiopathic inflammatory myopathies.特发性炎性肌病的心血管表现。
Clin Rheumatol. 2023 Oct;42(10):2557-2575. doi: 10.1007/s10067-023-06599-4. Epub 2023 May 6.

本文引用的文献

1
Idiopathic inflammatory myopathies.特发性炎性肌病
Nat Rev Dis Primers. 2021 Dec 2;7(1):86. doi: 10.1038/s41572-021-00321-x.
2
Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study.皮肌炎和多发性肌炎患者持续存在过早死亡率差距:一项基于英国普通人群的队列研究。
Rheumatology (Oxford). 2021 Jun 18;60(6):2653-2660. doi: 10.1093/rheumatology/keaa661.
3
High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.特发性炎性肌病患者的高密度脂蛋白功能异常。
Rheumatology (Oxford). 2020 Nov 1;59(11):3515-3525. doi: 10.1093/rheumatology/keaa273.
4
Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis.特发性炎症性肌病和类风湿关节炎患者在确诊后 5 年内发生心血管事件的风险相似。
Clin Rheumatol. 2021 Jan;40(1):231-238. doi: 10.1007/s10067-020-05237-7. Epub 2020 Jun 22.
5
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.特发性炎性肌病患者欧洲联合队列中肌炎自身抗体的频率、互斥性和临床关联。
J Autoimmun. 2019 Jul;101:48-55. doi: 10.1016/j.jaut.2019.04.001. Epub 2019 Apr 13.
6
Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan.特发性炎性肌病患者患冠心病的风险增加:台湾一项全国性人群研究。
Rheumatology (Oxford). 2019 Nov 1;58(11):1935-1941. doi: 10.1093/rheumatology/kez076.
7
Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study.特发性炎性肌病中的急性冠状动脉综合征:一项基于人群的研究。
J Rheumatol. 2019 Nov;46(11):1509-1514. doi: 10.3899/jrheum.181248. Epub 2019 Mar 15.
8
The expression level of miR-155 in plasma and peripheral blood mononuclear cells in coronary artery disease patients and the associations of these levels with the apoptosis rate of peripheral blood mononuclear cells.冠心病患者血浆及外周血单个核细胞中miR-155的表达水平及其与外周血单个核细胞凋亡率的相关性。
Exp Ther Med. 2018 Dec;16(6):4373-4378. doi: 10.3892/etm.2018.6797. Epub 2018 Sep 26.
9
Risk of Coronary Artery Disease in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.系统性红斑狼疮患者患冠状动脉疾病的风险:系统评价和荟萃分析。
Am J Med Sci. 2018 Nov;356(5):451-463. doi: 10.1016/j.amjms.2018.08.001. Epub 2018 Aug 8.
10
Proton pump inhibitors are not associated with inflammatory myopathies: A case control study.质子泵抑制剂与炎性肌病无关:一项病例对照研究。
Muscle Nerve. 2018 Dec;58(6):855-857. doi: 10.1002/mus.26336. Epub 2018 Oct 17.